Cited by 3,012Muscle Physiology and DisordersFOXO transcription factor regulationMuscle metabolism and nutrition

Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy.

Open access
Sandri, Marco, Sandri, Claudia, Gilbert, Alex, Skurk, Carsten, Calabria, Elisa, Picard, Anne, Walsh, Kenneth, Schiaffino, Stefano +2 more·2004·Cell

Abstract

Skeletal muscle atrophy is a debilitating response to fasting, disuse, cancer, and other systemic diseases. In atrophying muscles, the ubiquitin ligase, atrogin-1 (MAFbx), is dramatically induced, and this response is necessary for rapid atrophy. Here, we show that in cultured myotubes undergoing atrophy, the activity of the PI3K/AKT pathway decreases, leading to activation of Foxo transcription factors and atrogin-1 induction. IGF-1 treatment or AKT overexpression inhibits Foxo and atrogin-1 expression. Moreover, constitutively active Foxo3 acts on the atrogin-1 promoter to cause atrogin-1 transcription and dramatic atrophy of myotubes and muscle fibers. When Foxo activation is blocked by a dominant-negative construct in myotubes or by RNAi in mouse muscles in vivo, atrogin-1 induction during starvation and atrophy of myotubes induced by glucocorticoids are prevented. Thus, forkhead factor(s) play a critical role in the development of muscle atrophy, and inhibition of Foxo factors is an attractive approach to combat muscle wasting.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0092-8674(04)00400-3

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Two muscle-specific E3 ubiquitin ligases, MuRF1 and MAFbx, are key regulators of proteasomal proteolysis in skeletal muscle, especially under atrophy-inducing conditions.

    “Two muscle-specific E3 ubiquitin ligases, muscle RING finger 1 (MuRF1, also known as TRIM63) and muscle atrophy F-Box (MAFbx, also known as atrogin-1 or FBXO32), are thought to be key regulators of proteasomal proteolysis in skeletal muscle, especially under atrophy-inducing conditions (Cai et al., 2004; Sandri et al., 2004; Stitt et al., 2004).”

    From Proteasome dysfunction induces muscle growth defects and protein aggregation (2014) · cites this paper as Sandri et al., 2004

    In “IGF-1 and Insulin Suppress an Atrophy Program” (page unavailable), the paper links atrogin-1 and MuRF1 expression to catabolic conditions and muscle wasting. It also says their precise functions in wasting remain unclear. The copy therefore supports their proposed role in atrophy, but does not establish the more specific claim that both regulate proteasomal proteolysis. (LLM, conf=0.81)

    Experimental — accuracy not yet measured
  • Two muscle-specific E3 ubiquitin ligases, MuRF1 and Atrogin1, are thought to be key regulators of proteasomal proteolysis in skeletal muscle, especially under atrophy-inducing conditions.

    “Two muscle-specific E3 ubiquitin ligases, MuRF1 and Atrogin1, are thought to be key regulators of proteasomal proteolysis in skeletal muscle, especially under atrophy-inducing conditions (Cai et al., 2004; Sandri et al., 2004).”

    From Inducible Rpt3, a Proteasome Component, Knockout in Adult Skeletal Muscle Results in Muscle Atrophy (2020) · cites this paper as Sandri et al., 2004

    In “IGF-1 and Insulin Suppress an Atrophy Program” (page unavailable), the paper links atrogin-1 and MuRF1 expression to catabolic conditions and muscle wasting, and associates atrophy-related ubiquitin ligases with protein breakdown. It also says their precise functions in muscle wasting remain unclear; the available body-text passages do not establish that both are key regulators specifically of proteasomal proteolysis. (LLM, conf=0.78)

    Experimental — accuracy not yet measured
  • Atrogin-1 plays a key role in muscle atrophy as muscle specific ubiquitin ligase.

    “Atrogin-1 plays a key role in muscle atrophy as muscle specific ubiquitin ligase.”
  • FoxO family transcription factors (FoxO1, FoxO3, FoxO4) are critical mediators of the catabolic response during atrophy.

    “FoxO family of transcription factors (FoxO1, FoxO3, and FoxO4) are critical mediators of the catabolic response during atrophy [9, 15, 16].”
  • The IGF1-AKT-mTOR axis increases protein synthesis by stimulating the translational machinery and simultaneously blocks FoxO transcription factors and protein degradation.

    “The IGF1–AKT-–mTOR axis increases protein synthesis by stimulating the translational machinery and simultaneously blocks FoxOs transcription factors and protein degradation [9].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L.
Affiliations
  • Harvard University (US)
  • Veneto Institute of Molecular Medicine (IT)
  • Beth Israel Deaconess Medical Center (US)
  • Boston University (US)
Corresponding author
  • Lecker, Stewart H
  • Goldberg, Alfred L
Venue
Cell
Publisher
Elsevier BV
Published
2004-04
Volume
117
Issue
3
Pages
399-412
ISSN
0092-8674 (ISSN-L)
OpenAlex
W2033797333
Cited by
3,012
References
41
Citations by year
2026: 129 · 2025: 122 · 2024: 121 · 2023: 118 · 2022: 141 · 2021: 153 · 2020: 165 · 2019: 159 · 2018: 151 · 2017: 117 · 2016: 134 · 2015: 171 · 2014: 176 · 2013: 177 · 2012: 150
FWCI
33.75
Type
journal article
Language
en
Open access
Locations
  • Cell (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion)
Funders
  • National Space Biomedical Research Institute
  • European Commission (QLRT-2000-00530)
  • National Institutes of Health (DK02707, DK62307)
  • Ministero dell’Istruzione, dell’Università e della Ricerca
  • Agenzia Spaziale Italiana
  • Muscular Dystrophy Association
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Muscle metabolism and nutrition
Keywords
FOXO transcription factors, atrogin-1, skeletal muscle atrophy, ubiquitin ligase, PI3K/Akt signaling, insulin-like growth factor I, FOXO3, forkhead transcription factor, starvation, glucocorticoids, myotubes, muscle atrophy, transcriptional regulation
MeSH terms
Adenoviridae, Animals, Cells, Cultured, Cloning, Molecular, Fasting, Gene Expression Regulation, Genetic Vectors, Glucocorticoids, Insulin-Like Growth Factor I, Ligases, Models, Biological, Muscle Proteins, Muscular Atrophy, Promoter Regions, Genetic, Proto-Oncogene Proteins, Transcription Factors, Signal Transduction, Protein Serine-Threonine Kinases, Muscle, Skeletal, Phosphatidylinositol 3-Kinases, Muscle Cells, RNA Interference, Ubiquitin-Protein Ligases, SKP Cullin F-Box Protein Ligases, Proto-Oncogene Proteins c-akt, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review